YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Quality Assessment of Outpatient Antibiotic Consumptions in Korea Compared with Other Countries

항생제 사용의 질 지표를 이용한 국내 외래 항생제 사용현황의 국제 비교

  • Received : 2014.02.18
  • Accepted : 2014.06.05
  • Published : 2014.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study aimed to assess the quality of outpatient antibiotic consumption in Korea compared with other countries. We used the National Health Insurance claims data for outpatient services in March, June, September, and December in 2012 and calculated nine indicator values based on the 12 European Surveillance of Antimicrobial Consumption (ESAC) drug-specific quality indicators. Indicator values in this study reflect the yearly use of antibiotic expressed in defined daily doses for 1,000 inhabitants per day (DID) and the use of main subclasses of antibiotics expressed in DID and as percentage of the total antibiotic use. Korea showed lower quality in the consumption of total antibiotics (J01), especially in the use of Cephalosporins (J01D) expressed in DID. Korea also showed low quality with regard to the use of narrow/broad spectrum antibiotics. The percentage of the use of narrow-spectrum Penicillins (J01CE) was lowest in Korea. The quality on the use of the third- and fourth-generation cephalosporin (J01(DD+DE)) was the fourth lowest among 26 countries. High rates of antibiotic resistance and payment system based on fee-for-service might have influenced on the high consumption of the broad spectrum antibiotics in Korea. It needs to further investigate the use of broad-spectrum antibiotics to identify the target of strategies promoting quality use of antibiotics in Korea.

Keywords

References

  1. 김성철, 박용철, 김보금, 남두현 : 울산 지역 소아청소년과 및 이비인후과에서의 항생제 처방 형태. 한국임상약학회지 20, 145 (2010).
  2. Dickerson, L. M., Mainous III, A. G. and Carek, P. J. : The pharmacist's role in promoting optimal antimicrobial use. Pharmacotherapy 20, 711 (2000). https://doi.org/10.1592/phco.20.7.711.35171
  3. Bronzwaer, S. L., Cars, O., Buchholz, U., Molstad, S., Goettsch, W., Veldhuijzen, I. K., Kool, J. L., Sprenger, M. J. and Degener, J. E. : European antimicrobial resistance surveillance system : A european study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8, 278 (2002). https://doi.org/10.3201/eid0803.010192
  4. Goossens, H., Ferech, M., Vander Stichele, R. and Elseviers, M. : ESAC Project Group. : Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365, 579 (2005). https://doi.org/10.1016/S0140-6736(05)17907-0
  5. American Society of Microbiology : Report of the ASM task force on antibiotic resistance. Antimicrob. Agents Chemother. Suppl, 1 (1995).
  6. Ashiru-Oredope, D., Sharland, M., Charani, E., McNulty, C. and Cooke, J. : ARHAI Antimicrobial Stewardship Group : Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart-Then Focus. J Antimicrob Chemother. 67, i51 (2012). https://doi.org/10.1093/jac/dks202
  7. Albrich, W., Monnet, D. and Harbarth, S. : Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg. Infect. 10, 514 (2004). https://doi.org/10.3201/eid1003.030252
  8. 장영식, 도세록, 박실비아, 이연희, 오미애, 이의경, 김대업, 진재현, 장현경, 함선유 : 2012년도 의약품 소비량 및 판매액통계조사, 보건복지부.한국보건사회연구원 p. 139 (2013).
  9. Song, J. H., Jung, S. I., Ko, K. S., Kim, N. Y., Son, J. S., Chang, H. H., Ki, H. K., Oh, W. S., Suh, J. Y., Peck, K. R., Lee, N. Y., Yang, Y., Lu, Q., Chongthaleong, A., Chiu, C. H., Lalitha, M. K., Perera, J., Yee, T. T., Kumarasinghe, G., Jamal, F., Kamarulzaman, A., Parasakthi, N., Van, P. H., Carlos, C., So, T., Ng, T. K. and Shibl, A. : High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob. Agents Chemother. 48, 2101 (2004). https://doi.org/10.1128/AAC.48.6.2101-2107.2004
  10. 송윤경, 이현경, 지은희, 오정미 : 의약분업 이후 의원 및 약국에서의 항생제 사용 실태. 한국임상약학회지 21, 332 (2011).
  11. 건강보험심사평가원 : 2005년 3사분기 약제급여적정성평가 결과 (2006).
  12. 건강보험심사평가원 : 2011년 상반기 약제급여적정성평가 결과 (2012).
  13. 건강보험심사평가원 : 2012년 상반기 약제급여적정성평가 결과 (2013a).
  14. 건강보험심사평가원 : 2012년 하반기 약제급여적정성평가 결과 (2013b).
  15. 박실비아, 장영식, 채수미, 박은자, 이의경, 이인향 : 2011년도 의약품 소비량 및 판매액 통계 심층분석, 보건복지부.한국보건사회연구원 p. 131 (2012).
  16. Coenen, S., Ferech, M., Haaijer-Ruskamp, F. M., Butler, C. C., Vander Stichele, R. H., Verheij, T. J., Monnet, D. L., Little, P. and Goossens, H. : ESAC Project Group : European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual. Saf. Health Care. 16, 440 (2007). https://doi.org/10.1136/qshc.2006.021121
  17. Adriaenssens, N., Coenen, S., Tonkin-Crine, S., Verheij, T. J. M., Little, P. and Goossens, H., on behalf of the ESAC Project Group : European Surveillance of Antimicrobial Consumptions (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual. Saf. 20, 764 (2011). https://doi.org/10.1136/bmjqs.2010.049049
  18. Wise, R., Hart, T., Cars, O., Streulens, M., Helmuth, R., Huovinen, P. and Sprenger, M. : Antimicrobial resistance. Is a major threat to public health. BMJ 317, 609 (1998) https://doi.org/10.1136/bmj.317.7159.609
  19. 김윤정, 전현지, 이정우, 홍경욱, 김상일, 위성헌, 김양리, 강문원 : 국내 항균제의 사용 실태와 변화 추세(V). Infection & Chemotherapy 44, 411 (2012). https://doi.org/10.3947/ic.2012.44.6.411
  20. Steinman, M. A., Landefeld, C. S. and Gonzales, R. : Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 289, 719 (2003). https://doi.org/10.1001/jama.289.6.719
  21. Bergan, T. : Antibiotic usage in Nordic countries. Int. J. Antimicrob. Agents 18, 279 (2001). https://doi.org/10.1016/S0924-8579(01)00382-X
  22. OECD : Health at a Glance 2013, OECD p. 165 (2013).
  23. van Duijn, H. J., Kuyvenhoven, M. M., Butler, C. C., Coenen, S. and Verheij, T. J. : Variation in outpatient antibiotic use in three European countries: exploration of possible determinants. Eur. J. Gen. Pract. 11, 139 (2005). https://doi.org/10.3109/13814780509178258
  24. Ferech, M., Coenen, S., Malhotra-Kumar, S., Dvorakova, K., Hendrickx, E., Suetens, C. and Goossens, H. : ESAC Project Group : European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J. Antimicrob. Chemother. 58, 401 (2006). https://doi.org/10.1093/jac/dkl188
  25. Adriaenssens, N., Coenen, S., Versporten, A., Muller, A., Minalu, G., Faes, C., Vankerckhoven, V., Aerts, M., Hens, N., Molenberghs, G. and Goossens, H. : ESAC Project Group : European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J. Antimicrob. Chemother. 66, vi47 (2011).
  26. Hutchinson, J. M. and Foley, R. N. : Method of physician remuneration and rates of antibiotic prescription. CMAJ 160, 1013 (1999).